These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 23567920)

  • 1. The relationship between severity of the disease and circulating nucleosomes in psoriasis patients.
    Dilek AR; Dilek N; Saral Y; Yüksel D
    Arch Dermatol Res; 2013 Aug; 305(6):483-7. PubMed ID: 23567920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long pentraxin 3: a marker of inflammation in untreated psoriatic patients.
    Bevelacqua V; Libra M; Mazzarino MC; Gangemi P; Nicotra G; Curatolo S; Massimino D; Plumari A; Merito P; Valente G; Stivala F; La Greca S; Malaponte G
    Int J Mol Med; 2006 Sep; 18(3):415-23. PubMed ID: 16865225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of interleukin-8, tumor necrosis factor-α and γ-interferon in Egyptian psoriatic patients and correlation with disease severity.
    Abdel-Hamid MF; Aly DG; Saad NE; Emam HM; Ayoub DF
    J Dermatol; 2011 May; 38(5):442-6. PubMed ID: 21352285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated serum levels of calcium-binding S100 proteins A8 and A9 reflect disease activity and abnormal differentiation of keratinocytes in psoriasis.
    Benoit S; Toksoy A; Ahlmann M; Schmidt M; Sunderkötter C; Foell D; Pasparakis M; Roth J; Goebeler M
    Br J Dermatol; 2006 Jul; 155(1):62-6. PubMed ID: 16792753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity.
    Arican O; Aral M; Sasmaz S; Ciragil P
    Mediators Inflamm; 2005 Oct; 2005(5):273-9. PubMed ID: 16258194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in circulating cell-free DNA and nucleosomes in patients with exacerbated psoriasis.
    Beranek M; Fiala Z; Kremlacek J; Andrys C; Krejsek J; Hamakova K; Chmelarova M; Palicka V; Borska L
    Arch Dermatol Res; 2017 Dec; 309(10):815-821. PubMed ID: 29027583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum and skin levels of miR-369-3p in patients with psoriasis and their correlation with disease severity.
    Guo S; Zhang W; Wei C; Wang L; Zhu G; Shi Q; Li S; Ge R; Li K; Gao L; Gao T; Wang G; Li C
    Eur J Dermatol; 2013; 23(5):608-13. PubMed ID: 24135466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of TWEAK in patients with psoriasis vulgaris.
    Bilgiç Ö; Sivrikaya A; Toker A; Ünlü A; Altınyazar C
    Cytokine; 2016 Jan; 77():10-3. PubMed ID: 26499979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sequential histological and immunohistochemical assessment of proliferation and apoptotic markers during treatment of psoriasis with antitumor necrosis factor alpha (infliximab)].
    Gómez-Mateo C; Avalos-Peralta SP; Ríos-Martín JJ; Carrizosa-Esquivel AM; González-Cámpora R; Camacho-Martínez F
    Actas Dermosifiliogr; 2009 Jun; 100(5):420-4. PubMed ID: 19558920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of the inhibitor of apoptosis protein survivin in keratinocytes and endothelial cells in psoriasis skin following infliximab therapy.
    Markham T; Mathews C; Rogers S; Mullan R; Bresnihan B; Fitzgerald O; Veale DJ; Fearon U
    Br J Dermatol; 2006 Dec; 155(6):1191-6. PubMed ID: 17107388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum TNF-alpha levels correlate with disease severity and are reduced by effective therapy in plaque-type psoriasis.
    Mussi A; Bonifati C; Carducci M; D'Agosto G; Pimpinelli F; D'Urso D; D'Auria L; Fazio M; Ameglio F
    J Biol Regul Homeost Agents; 1997; 11(3):115-8. PubMed ID: 9498161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of infliximab on keratinocyte apoptosis in psoriasis patients.
    Raho G; Vena GA; Bizzoca A; Cassano N; Garofalo E; Congedo M; Gennarini G
    Immunopharmacol Immunotoxicol; 2011 Mar; 33(1):227-31. PubMed ID: 20507213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum concentrations of interleukin-2 and tumour necrosis factor-α under cyclosporine versus acitretin treatment in plaque-type psoriasis.
    Akçali C; Guven EH; Kirtak N; Inaloz HS; Ozgoztasi O; Guvenc U
    J Int Med Res; 2014 Oct; 42(5):1118-22. PubMed ID: 25143337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum interferon-gamma is a psoriasis severity and prognostic marker.
    Abdallah MA; Abdel-Hamid MF; Kotb AM; Mabrouk EA
    Cutis; 2009 Sep; 84(3):163-8. PubMed ID: 19842576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Visfatin, Adiponectin, and Tumor Necrosis Factor Alpha (TNF-α) Levels in Patients with Psoriasis and their Correlation with Disease Severity.
    Sereflican B; Goksugur N; Bugdayci G; Polat M; Haydar Parlak A
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):13-9. PubMed ID: 27149125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nature of cell kinetics in psoriatic epidermis.
    Doger FK; Dikicioglu E; Ergin F; Unal E; Sendur N; Uslu M
    J Cutan Pathol; 2007 Mar; 34(3):257-63. PubMed ID: 17302610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of inflammatory markers in assessing disease severity and response to treatment in patients with psoriasis treated with etanercept.
    Kanelleas A; Liapi C; Katoulis A; Stavropoulos P; Avgerinou G; Georgala S; Economopoulos T; Stavrianeas NG; Katsambas A
    Clin Exp Dermatol; 2011 Dec; 36(8):845-50. PubMed ID: 21790728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infliximab restores the balance between pro- and anti-apoptotic proteins in regressing psoriatic lesions.
    Kokolakis G; Giannikaki E; Stathopoulos E; Avramidis G; Tosca AD; Krüger-Krasagakis S
    Br J Dermatol; 2012 Mar; 166(3):491-7. PubMed ID: 21985184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated serum levels of interleukin 21 are associated with disease severity in patients with psoriasis.
    He Z; Jin L; Liu ZF; Hu L; Dang EL; Feng ZZ; Li QJ; Wang G
    Br J Dermatol; 2012 Jul; 167(1):191-3. PubMed ID: 22356196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and immunohistochemical assessment of the effect of cyclosporin in keratinocytes and dermal dendrocytes in psoriasis.
    Lago E; Carneiro S; Cuzzi T; Magalhães G; Cássia F; Pessanha F; Ramos-e-Silva M
    J Cutan Pathol; 2007 Jan; 34(1):15-21. PubMed ID: 17214849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.